Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Castlight Health (CSLT) Share Price
Media headlines about Castlight Health (NYSE:CSLT) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Castlight Health earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news headlines about the software maker an impact score of 44.4371480959695 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Castlight Health (CSLT) Downgraded by Zacks Investment Research (americanbankingnews.com)
- Castlight Health Inc (CSLT) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- Zacks: Analysts Anticipate Castlight Health Inc (CSLT) Will Announce Earnings of -$0.05 Per Share (americanbankingnews.com)
- Castlight Health, Inc. – Value Analysis (NYSE:CSLT) : December 26, 2017 (finance.yahoo.com)
- ETFs with exposure to Castlight Health, Inc. : December 27, 2017 (finance.yahoo.com)
Castlight Health (CSLT) traded down $0.15 during trading hours on Tuesday, reaching $3.75. 269,200 shares of the company were exchanged, compared to its average volume of 362,769. Castlight Health has a 12 month low of $3.05 and a 12 month high of $5.10. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.94 and a quick ratio of 1.94. The stock has a market capitalization of $501.52, a PE ratio of -7.98 and a beta of 1.66.
Castlight Health (NYSE:CSLT) last posted its earnings results on Wednesday, October 25th. The software maker reported ($0.05) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.07) by $0.02. Castlight Health had a negative net margin of 45.14% and a negative return on equity of 32.57%. The company had revenue of $34.60 million during the quarter, compared to analysts’ expectations of $34.61 million. During the same quarter in the prior year, the company posted ($0.05) earnings per share. Castlight Health’s revenue for the quarter was up 35.7% compared to the same quarter last year. equities analysts anticipate that Castlight Health will post -0.43 earnings per share for the current fiscal year.
A number of equities analysts have recently issued reports on CSLT shares. BidaskClub upgraded shares of Castlight Health from a “strong sell” rating to a “sell” rating in a research note on Wednesday, September 13th. Canaccord Genuity upgraded shares of Castlight Health from a “hold” rating to a “buy” rating in a research note on Tuesday, October 10th. Cantor Fitzgerald reiterated a “hold” rating and set a $5.00 price objective on shares of Castlight Health in a research note on Wednesday, October 25th. Chardan Capital dropped their price objective on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating on the stock in a research note on Thursday, October 26th. Finally, Zacks Investment Research upgraded shares of Castlight Health from a “hold” rating to a “buy” rating and set a $4.50 price objective on the stock in a research note on Monday, October 30th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $5.22.
In related news, President Robert Derek Newell purchased 30,000 shares of the firm’s stock in a transaction on Friday, October 27th. The stock was acquired at an average price of $3.95 per share, with a total value of $118,500.00. Following the completion of the acquisition, the president now owns 128,671 shares in the company, valued at approximately $508,250.45. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Mangini Siobhan Nolan sold 8,866 shares of the firm’s stock in a transaction on Friday, November 17th. The stock was sold at an average price of $3.70, for a total transaction of $32,804.20. Following the completion of the transaction, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at approximately $290,675.70. The disclosure for this sale can be found here. Insiders have sold 22,778 shares of company stock valued at $84,411 in the last three months. 24.38% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-castlight-health-cslt-share-price/1791904.html.
Castlight Health Company Profile
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with Analyst Ratings Network's FREE daily email newsletter.